# Nasdaq:BLTE news releases

Nasdaq:BLTE press releases distributed through HARO Newswire to the journalists who cover the beat.

- **Releases in the last 90 days:** 584
- **Web page:** https://www.helpareporter.com/news-releases/nasdaqblte
- **RSS:** https://www.helpareporter.com/news-releases/nasdaqblte/rss.xml

### [Belite Bio Announces Extension of FDA Review Timeline for Tinlarebant NDA](https://www.helpareporter.com/news-releases/belite-bio-announces-extension-of-fda-review-timeline-for-tinlarebant)

November 20, 2026 · Belite Bio · Nasdaq:BLTE

SAN DIEGO, Nov. 20, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs,…
